| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |